Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Hilton Worldwide
HLT
$75.3B
| $356M | 0.25% |
2,817,513
-2,625,335
| -48% | -$346M |
|
|
SEE
102
DELISTED
Sealed Air
SEE
| $354M | 0.25% |
7,105,611
-6,493,333
| -48% | -$317M |
|
103
Cooper Companies
COO
$13.7B
| $345M | 0.25% |
4,173,860
-5,806,148
| -58% | -$428M |
|
104
O'Reilly Automotive
ORLY
$75.1B
| $337M | 0.24% |
5,985,855
-5,926,425
| -50% | -$319M |
|
105
Organon & Co
OGN
$3.56B
| $336M | 0.24% |
12,020,574
-12,612,144
| -51% | -$322M |
|
106
Hershey
HSY
$36.6B
| $334M | 0.24% |
1,441,444
-1,253,424
| -47% | -$289M |
|
107
Stryker
SYK
$129B
| $332M | 0.24% |
1,359,897
-1,613,395
| -54% | -$366M |
|
108
Illumina
ILMN
$28.7B
| $332M | 0.24% |
1,689,061
-1,958,260
| -54% | -$406M |
|
109
Costco
COST
$422B
| $330M | 0.24% |
722,821
-878,025
| -55% | -$429M |
|
|
NATI
110
DELISTED
National Instruments Corp
NATI
| $328M | 0.23% |
8,885,010
-8,776,526
| -50% | -$343M |
|
111
Deckers Outdoor
DECK
$13.6B
| $326M | 0.23% |
4,904,178
-7,620,750
| -61% | -$461M |
|
112
Walt Disney
DIS
$168B
| $320M | 0.23% |
3,677,873
-3,437,367
| -48% | -$329M |
|
113
Marvell Technology
MRVL
$170B
| $320M | 0.23% |
8,625,729
-10,010,921
| -54% | -$409M |
|
114
Goldman Sachs
GS
$309B
| $319M | 0.23% |
928,038
-843,292
| -48% | -$294M |
|
115
Global Payments
GPN
$23B
| $316M | 0.23% |
3,179,971
-3,887,333
| -55% | -$405M |
|
116
Medtronic
MDT
$108B
| $315M | 0.23% |
4,054,539
-3,516,483
| -46% | -$285M |
|
117
Ziff Davis
ZD
$1.93B
| $307M | 0.22% |
3,883,760
-3,893,056
| -50% | -$313M |
|
118
Sysco
SYY
$40.2B
| $304M | 0.22% |
3,978,912
-3,674,254
| -48% | -$297M |
|
119
DexCom
DXCM
$28.3B
| $302M | 0.22% |
2,663,484
-7,108,558
| -73% | -$780M |
|
120
Synopsys
SNPS
$74.5B
| $294M | 0.21% |
920,691
-1,445,241
| -61% | -$452M |
|
121
Revvity
RVTY
$12.1B
| $292M | 0.21% |
2,085,157
-2,080,247
| -50% | -$280M |
|
122
EOG Resources
EOG
$74.7B
| $291M | 0.21% |
2,247,489
-2,241,889
| -50% | -$298M |
|
123
Neurocrine Biosciences
NBIX
$17.7B
| $289M | 0.21% |
2,415,638
-7,438,030
| -75% | -$871M |
|
124
ServiceNow
NOW
$109B
| $287M | 0.2% |
3,692,180
-5,362,250
| -59% | -$419M |
|
125
Vaxcyte
PCVX
$8.01B
| $286M | 0.2% |
5,974,139
-3,101,363
| -34% | -$122M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.